(BMRN) Biomarin - Performance -21.3% in 12m
Compare BMRN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-27.09%
#51 in Group
Rel. Strength
26.80%
#5593 in Universe
Total Return 12m
-21.29%
#66 in Group
Total Return 5y
-17.46%
#46 in Group
P/E 30.7
73th Percentile in Group
P/E Forward 17.0
62th Percentile in Group
PEG 0.46
77th Percentile in Group
FCF Yield 3.83%
88th Percentile in Group
12m Total Return: BMRN (-21.3%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: BMRN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BMRN
Total Return (including Dividends) | BMRN | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.80% | -5.85% | -3.01% |
3 Months | 2.75% | -11.95% | -3.15% |
12 Months | -21.29% | -11.00% | 10.19% |
5 Years | -17.46% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | BMRN | XBI | S&P 500 |
1 Month | -9.20% | -59.8% | -5.5% |
3 Months | 75.4% | -70.5% | -58.4% |
12 Months | -71.4% | -6.9% | 84.1% |
5 Years | -12.2% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #65 | 2.17% | -0.82% |
3 Month | #32 | 16.7% | 6.10% |
12 Month | #66 | -11.6% | -28.6% |
5 Years | #52 | -18.0% | -64.0% |
FAQs
Does BMRN Biomarin outperforms the market?
No,
over the last 12 months BMRN made -21.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months BMRN made 2.75%, while XBI made -11.95%.
Over the last 3 months BMRN made 2.75%, while XBI made -11.95%.
Performance Comparison BMRN vs Indeces and Sectors
BMRN vs. Indices BMRN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.70% | -0.79% | -1.79% | -31.5% |
US NASDAQ 100 | QQQ | -2.72% | 0.26% | -1.02% | -29.9% |
US Dow Jones Industrial 30 | DIA | -3.90% | -1.66% | -2.71% | -30.8% |
German DAX 40 | DAX | -2.40% | -0.42% | -18.6% | -43.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -3.41% | -4.03% | 13.4% | -30.4% |
Hongkong Hang Seng | HSI | -5.67% | -6.57% | 7.43% | -38.6% |
India NIFTY 50 | INDA | -4.73% | -11.7% | 8.56% | -22.0% |
Brasil Bovespa | EWZ | -3.81% | -12.1% | 6.21% | -9.55% |
BMRN vs. Sectors BMRN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.16% | 0.01% | -9.90% | -40.5% |
Consumer Discretionary | XLY | -4.46% | 0.03% | -5.15% | -35.4% |
Consumer Staples | XLP | -6.49% | -1.96% | -2.63% | -32.3% |
Energy | XLE | -4.79% | -11.8% | -7.37% | -22.1% |
Financial | XLF | -4.18% | -1.10% | -14.0% | -43.5% |
Health Care | XLV | -4.12% | -0.64% | 2.91% | -23.0% |
Industrial | XLI | -4.01% | -3.11% | -1.08% | -29.8% |
Materials | XLB | -4.80% | -4.31% | 6.32% | -17.4% |
Real Estate | XLRE | -5.74% | -1.11% | 1.33% | -34.7% |
Technology | XLK | -2.57% | 0.21% | 3.33% | -23.3% |
Utilities | XLU | -6.99% | -4.62% | -0.91% | -46.5% |
Aerospace & Defense | XAR | -3.10% | -5.08% | -5.71% | -42.2% |
Biotech | XBI | 0.86% | 2.05% | 15.9% | -10.3% |
Homebuilder | XHB | -4.20% | -3.95% | 17.6% | -13.6% |
Retail | XRT | -6.0% | -3.30% | 2.29% | -16.5% |